OPRX stock · PATH stock

OPRX vs PATH

OPTIMIZERx Corp (OPRX) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.

OPTIMIZERx Corp (OPRX) is a health information services company listed on US.

Uipath Inc (PATH) is a software - infrastructure company listed on US.

Latest reported OPRX revenue for 2024-12-31 was $92.1M. Net income was -$20.1M. Revenue was up 28.8% from 2023-12-31 to 2024-12-31. OPRX currently screens at market cap $234.9M.

Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.

OPRX currently screens at market cap $234.9M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.

Not investment advice. Open the OPRX and PATH stock pages for the full models.

Not investment advice.

Popular Stock Comparisons